NC
ELAN icon

nVerses Capital’s Elanco Animal Health ELAN Stock Holding History

nVerses Capital’s Portfolio ELAN Stock Details ELAN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-2,200
Closed -$31.7K – 1111
2024
Q2 		$31.7K Buy
+2,200
New +$35.2K 0.02% 685

Other funds holding ELAN

Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BCIM
Black Creek Investment Management Toronto, Ontario, Canada $1.78B AUM 5.83% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
SCM
Shapiro Capital Management Atlanta, Georgia $1.65B AUM 26.74% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $11B AUM 3.37% 1-Year Est. Return

nVerses Capital's ELAN Position: Q3 2024 in Review

nVerses Capital sold out of Elanco Animal Health (ELAN) in Q3 2024, closing a stake of 2,200 shares — an estimated $31.7K sold.

nVerses Capital first reported a position in ELAN in Q2 2024 and held it in 1 quarter. The position peaked at $31.7K in Q2 2024. 388 funds tracked by Wall St. Rank hold ELAN as of Q3 2024.

  • nVerses Capital reported no remaining Elanco Animal Health position as of Q3 2024 after selling out during the quarter.
  • nVerses Capital sold 2,200 Elanco Animal Health shares in Q3 2024, an estimated $31.7K.
  • nVerses Capital first reported a position in Elanco Animal Health in Q2 2024 and held it in 1 quarter.
  • nVerses Capital's Elanco Animal Health position peaked at $31.7K in Q2 2024.
  • 388 funds tracked by Wall St. Rank held Elanco Animal Health as of Q3 2024.

Based on nVerses Capital's 13F filing for Q3 2024, filed 16 Oct 2024.